AWARDDELIVERY ORDEROther than small business
Delivery order 75N91018F00005MIEDZYNARODOWY INSTYTUT ONKOLOGII MOLEKULARNEJ
Overview
Award facts
- Net obligations
- $35.75K
- $35,750of $35.75K potential value
- Outlays (paid to date)
- $0
- $0 paid of $35.75K obligated$0
- Period of performance
- Sep 17, 2018 to Sep 16, 2020
- Ended
- Modifications
- 4
- Latest action Jun 20, 2023
- Contract type
- Delivery order
- PIID 75N91018F00005
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF TSS FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM; 217 CASES FOR IMAGING. (217 CASES @ $250 PER CASE X 100%)
Dates and value
- Award date
- Signed on Sep 14, 2018
- Potential end of performance
- Sep 15, 2020
- Current value
- $35,750Base and exercised options
- Potential value (if all options are exercised)
- $35,750
- Parent contract vehicle
- HHSN261201600005I (IDC, multiple award) — 5 orders recorded under it
Obligations by fiscal year of action
- FY2023: -$42,750 (de-obligation)
- FY2019: $24,250
- FY2018: $54,250
Total across 3 fiscal years: $35,750
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 20, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationPOZNAN, POL
UEIQP7UJL8G76C3
CAGE code2993H
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeForeign government
Parent companyMIEDZYNARODOWY INSTYTUT ONKOLOGII MOLEKULARNEJ
Business types and certifications
Foreign government
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH NCI
- Funded from
- National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Poland
Classification and competition
Classification
- Product or service (PSC)
- 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (product)
Competition
- Extent competed
- Competed under SAPF
- Fair opportunity exception
- Follow-on action following competitive initial actionFOO
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- N02CO5441602(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 14, 2018Base obligation at award: $54,250
- Latest action
- Jun 20, 2023 — Supplemental agreement (within scope)Modification P00004; obligation change -$42,750
- Latest substantive action
- Jun 20, 2023 — Supplemental agreement (within scope)Modification P00004; obligation change -$42,750
- Actions by type
- Base award1
- Other administrative action2
- Supplemental agreement (within scope)1
- Option exercised1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$42,750
- Latest action: change in base and all options
- -$42,750
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- Other foreign entity (e.g. foreign government)O
- Country of product or service origin
- PolandPOL
- Place of manufacture
- Mfg outside U.S. - commercial information technologyH
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N910
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N910
- Treasury accounts
- 075-2018/2018-0849-000
- 075-2019/2019-0849-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression